These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 19559720)
41. Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy. Giannantoni A; Rossi A; Mearini E; Del Zingaro M; Porena M; Berardelli A J Urol; 2009 Oct; 182(4):1453-7. PubMed ID: 19683298 [TBL] [Abstract][Full Text] [Related]
42. Influence of age and gender on dose and effectiveness of botulinum toxin for laryngeal dystonia. Vasconcelos S; Birkent H; Sardesai MG; Merati AL; Hillel AD Laryngoscope; 2009 Oct; 119(10):2004-7. PubMed ID: 19572275 [TBL] [Abstract][Full Text] [Related]
43. Efficacy and Safety of a New Botulinum Toxin Type A Free of Complexing Proteins. Oh HM; Park JH; Song DH; Chung ME Toxins (Basel); 2015 Dec; 8(1):. PubMed ID: 26712786 [TBL] [Abstract][Full Text] [Related]
44. [Mechanisms of neuro-tropic disorders induced in skeletal muscles by botulinum toxin]. Mikhaĭlov VV Biull Eksp Biol Med; 1980 Jul; 89(7):25-7. PubMed ID: 7407365 [TBL] [Abstract][Full Text] [Related]
45. An improved electrophysiological method to study peripheral nerve regeneration in rats. Werdin F; Grüssinger H; Jaminet P; Kraus A; Manoli T; Danker T; Guenther E; Haerlec M; Schaller HE; Sinis N J Neurosci Methods; 2009 Aug; 182(1):71-7. PubMed ID: 19505504 [TBL] [Abstract][Full Text] [Related]
46. Comparative Pharmacodynamics Study of 3 Different Botulinum Toxin Type A Preparations in Mice. Kwak S; Kang WH; Rhee CH; Yang GH; Cruz DJM Dermatol Surg; 2020 Dec; 46(12):e132-e138. PubMed ID: 32251006 [TBL] [Abstract][Full Text] [Related]
47. OnabotulinumtoxinA Displays Greater Biological Activity Compared to IncobotulinumtoxinA, Demonstrating Non-Interchangeability in Both In Vitro and In Vivo Assays. Rupp D; Nicholson G; Canty D; Wang J; Rhéaume C; Le L; Steward LE; Washburn M; Jacky BP; Broide RS; Philipp-Dormston WG; Brin MF; Brideau-Andersen A Toxins (Basel); 2020 Jun; 12(6):. PubMed ID: 32545832 [TBL] [Abstract][Full Text] [Related]
48. [Comparison of non-invasive and invasive techniques in the treatment of patients with myofascial pain syndrome]. Gül K; Onal SA Agri; 2009 Jul; 21(3):104-12. PubMed ID: 19780001 [TBL] [Abstract][Full Text] [Related]
49. The combined use of forced cold air and topical anesthetic cream for analgesia during the treatment of palmar hyperhydrosis with botulinum toxin injections. Patel R; Halem M; Zaiac M J Drugs Dermatol; 2009 Oct; 8(10):948-51. PubMed ID: 19852126 [TBL] [Abstract][Full Text] [Related]
50. An initial assessment of the systemic pharmacokinetics of botulinum toxin. Ravichandran E; Gong Y; Al Saleem FH; Ancharski DM; Joshi SG; Simpson LL J Pharmacol Exp Ther; 2006 Sep; 318(3):1343-51. PubMed ID: 16782822 [TBL] [Abstract][Full Text] [Related]
51. Long-term efficacy and tolerability of 4-monthly versus yearly botulinum toxin type A treatment for lower-limb spasticity in children with cerebral palsy. Kanovský P; Bares M; Severa S; Richardson A; Dev Med Child Neurol; 2009 Jun; 51(6):436-45. PubMed ID: 19563586 [TBL] [Abstract][Full Text] [Related]
52. Treatment of severe achalasia during pregnancy with esophagoscopic injection of botulinum toxin A: a case report. Wataganara T; Leelakusolvong S; Sunsaneevithayakul P; Vantanasiri C J Perinatol; 2009 Sep; 29(9):637-9. PubMed ID: 19710656 [TBL] [Abstract][Full Text] [Related]
53. Dysport: pharmacological properties and factors that influence toxin action. Pickett A Toxicon; 2009 Oct; 54(5):683-9. PubMed ID: 19332087 [TBL] [Abstract][Full Text] [Related]
54. [Influence of neuromuscular blockade on motor evoked potential of forearm muscles]. Chen N; Zhou SJ; Yan HC; Xie Z Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(7):445-8. PubMed ID: 19567090 [TBL] [Abstract][Full Text] [Related]
55. The role of systemic handling in the pathophysiologic actions of botulinum toxin. Al-Saleem FH; Ancharski DM; Ravichandran E; Joshi SG; Singh AK; Gong Y; Simpson LL J Pharmacol Exp Ther; 2008 Sep; 326(3):856-63. PubMed ID: 18539649 [TBL] [Abstract][Full Text] [Related]
56. Production of vaccines against leading biowarfare toxins can utilize DNA scientific technology. Middlebrook JL Adv Drug Deliv Rev; 2005 Jun; 57(9):1415-23. PubMed ID: 15896873 [TBL] [Abstract][Full Text] [Related]
57. Electrodiagnosis of botulism and clinico-electrophysiological correlation. Witoonpanich R; Vichayanrat E; Tantisiriwit K; Rattanasiri S; Ingsathit A Clin Neurophysiol; 2009 Jun; 120(6):1135-8. PubMed ID: 19410507 [TBL] [Abstract][Full Text] [Related]